Your browser does not support iframes.
JERUSALEM--(BUSINESS WIRE)--Nov. 17, 2015--
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will host a live audio
webcast at the Jefferies Autumn 2015 Global Healthcare Conference. Eyal
Desheh will present on Thursday, November 19, 2015 at 11:20 AM GMT.
Teva Presentation at the Jefferies Autumn 2015 Global Healthcare
Eyal Desheh, Group EVP & CFO
Teva Pharmaceutical Industries Ltd.
Thursday, November 19, 2015
Live over the Internet – log on to the Web at the address above
and register for the event (approximately 10 minutes before). An
archive of the webcast will be available on Teva’s website.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) is a leading
global pharmaceutical company that delivers high-quality,
patient-centric healthcare solutions to millions of patients every day.
Headquartered in Israel, Teva is the world’s largest generic medicines
producer, leveraging its portfolio of more than 1,000 molecules to
produce a wide range of generic products in nearly every therapeutic
area. In specialty medicines, Teva has a world-leading position in
innovative treatments for disorders of the central nervous system,
including pain, as well as a strong portfolio of respiratory products.
Teva integrates its generics and specialty capabilities in its global
research and development division to create new ways of addressing unmet
patient needs by combining drug development capabilities with devices,
services and technologies. Teva's net revenues in 2014 amounted to $20.3
billion. For more information, visit www.tevapharm.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151117006032/en/
Source: Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.IR:United StatesKevin
C. Mannix, 215-591-8912Ran Meir, 215-591-3033orIsraelTomer
Amitai, 972 (3) 926-7656orPR:IsraelIris
Beck Codner, 972 (3) 926-7687orUnited StatesDenise
Bradley, 215-591-8974Nancy Leone, 215-284-0213